openPR Logo
Press release

Endobronchial Valves Market Assessment and Key Insights Analyzed till 2028 // Bulging key player - Pulmonx Corporation, Spiration Inc.

05-21-2019 09:20 AM CET | IT, New Media & Software

Press release from: Fact.MR

Endobronchial Valves Market Assessment and Key Insights

The major factor expected to drive the growth of the endobronchial valves market is growing awareness regarding procedure for bronchoscopic lung volume reduction in various lung-related diseases. The increasing prevalence of tobacco smoking worldwide is consequently expected to contribute to the growth of the Endobronchial Valves Market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1534

Endobronchial valves are specially designed one-way valves that allow the exhaled air to exit the lungs, but restrict the entry of inhaled air to the lung compartment. The endobronchial valve is used to decrease the lung volume in the condition of lung disease or more specifically emphysema. A commonly endoscopic approach is prescribed rather than thoracoscopic lung volume reduction surgery. The insertion of the endobronchial valve is performed by a delivery catheter, which is passed from the bronchoscope. An endobronchial valve is designed in such a way that it only prevents air uptake or inflation during the inhalation process, and allows the mucosa and exhaled air to exit or the lungs to deflate during the process of exaltation. The endobronchial valves come in different shapes and designs based on the use. Currently, the endobronchial valves are designed in duckbill and umbrella shape.

The chronic obstructive pulmonary disease (COPD) is one of the major lung disorders. With the growing geriatric population, who are more commonly susceptible to lung disease, the demand for endobronchial valve is expected to increase at a linear speed. Besides, growing air pollution has a significant impact on the increasing number of patients suffering with lung disorders, particularly severe emphysema and advanced emphysema. This is also considered as one of the major factors fueling the growth of the global endobronchial valves market over the forecast period. Efficiency of the endobronchial valves compared to the standard medical care in lung volume reduction methods and emphysema treatment is the other factor expected to propel the growth of the endobronchial valves market over the forecast period. However, the high cost associated with the procedure coupled with the post-operative adhesion issues associated with the valve are factors expected to restrict the growth of the endobronchial valves market over the forecast period.

Browse Full Report with TOC- https://www.factmr.com/report/1534/endobronchial-valves-market

The global market for endobronchial valves is still in the nascent stage. The global endobronchial valves market is projected to show steady growth as there is no particular substitute available for endobronchial valves in minimally invasive surgery for lung volume reduction. Due to increasing demand for endobronchial valves, manufacturers of endobronchial valve systems are mainly focused on clinical trials and research and development. In the forthcoming years, the global endobronchial valves market is expected to witness the entry of few new market players, which will increase the competition in the endobronchial valves market. The growing global population, predominantly geriatric, who are more susceptible to have a lung disease, the market for the endobronchial valves is expected to grow at a steady speed. Among the two product types, due to the ease in the implanting the duckbill-shaped endobronchial valves is expected to be the leading segment in the global endobronchial valves market over the forecast period. The ongoing clinical trials in various regions as such North America and Europe, especially in the U.K., are projected to offer new growth opportunities for the manufacturers operating in the endobronchial valves market.

Geographically, the global endobronchial valves market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant regional market for endobronchial valves owing to increasing healthcare spending and shift towards minimally invasive surgeries. The endobronchial valves market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the increasing healthcare spending in China and India. Europe is projected to hold second large share in the global endobronchial valves market over the forecast period.

The global market for endobronchial valves is consolidated with very few players operating in the global endobronchial valves market. Examples of some of the key players operating in the global endobronchial valves market are Pulmonx Corporation (Zephyr), Spiration Inc, etc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1534

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endobronchial Valves Market Assessment and Key Insights Analyzed till 2028 // Bulging key player - Pulmonx Corporation, Spiration Inc. here

News-ID: 1746748 • Views:

More Releases from Fact.MR

Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
04-19-2024 | Health & Medicine
Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034. The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9.5 billion by 2033.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
04-19-2024 | Health & Medicine
Fact.MR
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034. Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 2032
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032. Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its

All 5 Releases


More Releases for Endobronchial

Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc, e …
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Global Endobronchial Ultrasound Biopsy Market Overview & Competitive Research 20 …
ResearchMoz include new market research report "Endobronchial Ultrasound Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. This report analyzes the current and future scenario of the global endobronchial ultrasound biopsy market. Rise in geriatric population, high prevalence of lung cancer and other respiratory-related disorders, and increase in patient preference for minimally invasive surgeries are major drivers of
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc,
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc,
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Endobronchial Valves Market Augmented Expansion to be Registered by 2025
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply